Skip to main content

News Archive

News Archive - Skaggs School of Pharmacy and Pharmaceutical Sciences

UC San Diego Joins IBM World Community Grid’s Search for Zika Treatment

May 19, 2016

IBM's World Community Grid and scientists from Brazil, the Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego, and Rutgers New Jersey Medical School have launched OpenZika, a project to find drug candidates to treat Zika, a fast spreading virus that the World Health Organization has declared a global public health emergency.

UC San Diego to Participate in White House’s National Microbiome Initiative

May 13, 2016

On May 13, the White House Office of Science and Technology Policy (OSTP) announced a new National Microbiome Initiative, a coordinated effort to better understand microbiomes and to develop tools to protect and restore healthy microbiome function. OSTP is launching the initiative with a combined federal agency investment of more than $121 million. The University of California San Diego is a key participant in this effort, investing $12 million in its own microbiome research efforts.

UC San Diego Sparks New Cancer-Focused Startup, Oncternal, with Exclusive Antibody License

May 2, 2016

Oncternal Therapeutics, a new cancer-focused biotechnology startup, has signed a wide-ranging licensing agreement with UC San Diego to develop and commercialize antibodies and antibody-related binding agents.

Two-Day ‘Hackathon for Startups’ Hopes to Spark Student Innovations

May 2, 2016

The new “Startup UCSD,” described as a two-day hackathon for startups, encourages the creative, innovative, and problem-solving students at UC San Diego to bring their ideas to a venue where workshops, professional advisors, and campus resources can help bring those ideas to fruition.

Weak Brain Circadian Rhythms Cause Depression-Like Behavior in Mice

May 2, 2016

When the master pacemaker that normally synchronizes circadian rhythms in the brain is disrupted, that disruption causes helplessness, behavioral despair, and anxiety-like behavior in mice, say scientists at the University of California San Diego.

Fermentation Festival Leads to Rapid Response System at Center for Microbiome Innovation

April 26, 2016

While technological advances have made it easier to map our microbiomes and metabolomes, these studies typically take too long for that data to be medically useful. Researchers at the University of California San Diego Center for Microbiome Innovation used the 2016 San Diego Fermentation Festival as a test case for a novel rapid response system. In the study, published in mSystems, the team collected samples, analyzed data and reported conclusions in an unprecedented 48 hours.

Pollutants in Fish Inhibit Human’s Natural Defense System

April 15, 2016

In a new study, environmental pollutants found in fish were shown to obstruct the human body’s natural defense system to expel harmful toxins. The Scripps Institution of Oceanography at UC San Diego-led research team suggests that this information should be used to better assess the human health risks from eating contaminated seafood. The study was published in the April 15 issue of the journal Science Advances.

UC San Diego Scientists Receive $9.5 Million NIH Grant to Combat Antibiotic Resistance

April 12, 2016

Researchers at University of California, San Diego School of Medicine have received a five-year, $9.5-million award from the National Institute of Allergy and Infectious Diseases at the National Institutes of Health (NIH) to establish an interdisciplinary center to define the systems biology of antibiotic resistance. The program will be led by Bernhard Palsson, PhD, Distinguished Professor of Bioengineering and Pediatrics, and Victor Nizet, MD, professor of pediatrics and pharmacy.

San Diego to be Research Hub for New Human Vaccines Project

April 7, 2016

The University of California, San Diego, J. Craig Venter Institute, La Jolla Institute for Allergy and Immunology and The Scripps Research Institute have teamed up to create the “Mesa Consortium,” a new scientific hub for the Human Vaccines Project. Under a collaborative agreement, the Mesa Consortium and the Human Vaccine Project aim to transform current understanding of the human immune system and expedite development of vaccines and biologics to prevent and treat many global diseases.

UC San Diego’s Office of Innovation Names Director of Commercialization

March 14, 2016

The Office of Innovation and Commercialization (OIC) at UC San Diego has named a key new team leader to help guide the organization in its mission to create an all-campus “innovation ecosystem” and energize the creation of campus startups.
Category navigation with Social links